Discovery of Pyrazolo[3,4-<i>d</i>]pyridazinone Derivatives as Selective DDR1 Inhibitors via Deep Learning Based Design, Synthesis, and Biological Evaluation
作者:Xiaoqin Tan、Chunpu Li、Ruirui Yang、Sen Zhao、Fei Li、Xutong Li、Lifan Chen、Xiaozhe Wan、Xiaohong Liu、Tianbiao Yang、Xiaochu Tong、Tingyang Xu、Rongrong Cui、Hualiang Jiang、Sulin Zhang、Hong Liu、Mingyue Zheng
DOI:10.1021/acs.jmedchem.1c01205
日期:2022.1.13
receptor1 (DDR1) may lead to increased production of inflammatory cytokines, making DDR1 an attractive target for inflammatory bowel disease (IBD) therapy. A scaffold-based molecular design workflow was established and performed by integrating a deep generative model, kinase selectivity screening and molecular docking, leading to a novel DDR1 inhibitor compound 2, which showed potent DDR1 inhibition
盘状结构域受体 1 (DDR1) 的改变可能导致炎性细胞因子的产生增加,使 DDR1 成为炎症性肠病 (IBD) 治疗的有吸引力的靶点。通过整合深度生成模型、激酶选择性筛选和分子对接,建立并执行了基于支架的分子设计工作流程,从而产生了一种新型 DDR1 抑制剂化合物2,该化合物显示出有效的 DDR1 抑制曲线 (IC 50 = 10.6 ± 1.9 nM) 和对一组 430 种激酶具有出色的选择性(S (10) = 0.002,0.1 μM)。化合物2有效抑制细胞中促炎细胞因子的表达和 DDR1 自磷酸化,并且在葡聚糖硫酸钠 (DSS) 诱导的小鼠结肠炎模型中也显示出有希望的口服治疗效果。